Fig. 4From: An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorderGraph showing monitoring of the side effects over the course of the study, a significant decrease was observed in the MOSES score (p = 0.014)Back to article page